Akèy › Gliyòm › Ohio › Columbus
Etid klinik pou Gliyòm nan Columbus, OH
15 etid pou Gliyòm ap chèche patisipan nan sit nan ak bò kote Columbus (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Ap rekriteFaz 1/2
- Nationwide Children's Hospital, Columbus
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Ap rekriteFaz 2
- Ohio State University, Columbus
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Ap rekriteFaz 2
- Nationwide Children's Hospital, Columbus
Targeted Pediatric High-Grade Glioma Therapy
Ap rekriteEtid obsèvasyon
- Nationwide Children's Hospital, Columbus
Study of Olutasidenib and Temozolomide in HGG
Ap rekriteFaz 2
- Nationwide Children's Hospital, Columbus
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Ap rekriteFaz 2
- Nationwide Children's Hospital, Columbus
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Ap rekriteFaz 2
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Ap rekrite
- Ohio State University Medical Center, Columbus
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Ap rekriteFaz 1/2
- Nationwide Children's Hospital, Columbus
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Ap rekriteFaz 1 bonèVolontè an sante akeyi
- Nationwide Children's Hospital, Columbus
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Ap rekriteFaz 2
- Nationwide Children's Hospital, Columbus
Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
Ap rekriteFaz 1
- Ohio State University Comprehensive Cancer Center, Columbus
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Ap rekriteFaz 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Ap rekriteFaz 1 bonè
- Nationwide Children's Hospital, Columbus
Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells
Ap rekriteFaz 1
- Nationwide Children's Hospital, Columbus
Etid Gliyòm nan lòt vil
- New York City, NY25 etid
- Houston, TX23 etid
- Boston, MA20 etid
- Washington, DC19 etid
- Philadelphia, PA16 etid
- Miami, FL15 etid
- San Francisco, CA14 etid
- Chicago, IL13 etid
- Durham, NC12 etid
- Seattle, WA11 etid
- Los Angeles, CA10 etid
- St. Louis, MO10 etid
Lòt etid nan Columbus
- Kansè Poumon ki pa ti selil56 etid
- Kansè nan tete39 etid
- Kansè ovè39 etid
- Kansè (tout kalite)38 etid
- Kansè poumon37 etid
- Leksemi mieloïd egi35 etid
- Lukemi lenfositè kwonik28 etid
- Kansè Metastatik27 etid
- Kansè Endomèt25 etid
- Kansè kolorektal24 etid
- Kansè pwostat24 etid
- Myelom Miltip24 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.